Revvity Price to Free Cash Flow Ratio 2011-2025 | RVTY
Historical price to free cash flow ratio values for Revvity (RVTY) since 2011.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Revvity Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-13 | 93.40 | 22.28 | |
| 2025-06-30 | 96.58 | $4.19 | 23.04 |
| 2025-03-31 | 105.57 | $4.29 | 24.59 |
| 2024-12-31 | 111.30 | $4.41 | 25.24 |
| 2024-09-30 | 127.32 | $4.57 | 27.84 |
| 2024-06-30 | 104.44 | $3.09 | 33.83 |
| 2024-03-31 | 104.50 | $0.79 | 131.75 |
| 2023-12-31 | 108.72 | $0.08 | 1369.29 |
| 2023-09-30 | 110.03 | $-0.46 | 0.00 |
| 2023-06-30 | 118.00 | $1.21 | 97.80 |
| 2023-03-31 | 132.31 | $3.01 | 43.92 |
| 2022-12-31 | 139.15 | $4.70 | 29.61 |
| 2022-09-30 | 119.34 | $6.35 | 18.78 |
| 2022-06-30 | 140.98 | $7.53 | 18.72 |
| 2022-03-31 | 172.87 | $9.30 | 18.60 |
| 2021-12-31 | 199.15 | $11.35 | 17.54 |
| 2021-09-30 | 171.57 | $13.11 | 13.08 |
| 2021-06-30 | 152.81 | $12.43 | 12.29 |
| 2021-03-31 | 126.90 | $11.16 | 11.37 |
| 2020-12-31 | 141.87 | $7.43 | 19.09 |
| 2020-09-30 | 124.02 | $4.89 | 25.36 |
| 2020-06-30 | 96.86 | $3.99 | 24.28 |
| 2020-03-31 | 74.27 | $3.16 | 23.53 |
| 2019-12-31 | 95.73 | $2.58 | 37.10 |
| 2019-09-30 | 83.90 | $1.99 | 42.15 |
| 2019-06-30 | 94.83 | $2.18 | 43.60 |
| 2019-03-31 | 94.78 | $2.41 | 39.39 |
| 2018-12-31 | 77.20 | $2.29 | 33.66 |
| 2018-09-30 | 95.52 | $2.17 | 43.97 |
| 2018-06-30 | 71.85 | $1.61 | 44.57 |
| 2018-03-31 | 74.22 | $1.49 | 49.75 |
| 2017-12-31 | 71.61 | $2.26 | 31.70 |
| 2017-09-30 | 67.48 | $2.71 | 24.88 |
| 2017-06-30 | 66.60 | $2.68 | 24.82 |
| 2017-03-31 | 56.68 | $3.29 | 17.25 |
| 2016-12-31 | 50.84 | $3.08 | 16.50 |
| 2016-09-30 | 54.63 | $2.63 | 20.80 |
| 2016-06-30 | 50.97 | $2.70 | 18.88 |
| 2016-03-31 | 48.03 | $2.22 | 21.63 |
| 2015-12-31 | 51.94 | $2.28 | 22.74 |
| 2015-09-30 | 44.50 | $2.10 | 21.21 |
| 2015-06-30 | 50.90 | $2.11 | 24.07 |
| 2015-03-31 | 49.38 | $2.01 | 24.57 |
| 2014-12-31 | 42.16 | $2.26 | 18.66 |
| 2014-09-30 | 41.96 | $1.99 | 21.04 |
| 2014-06-30 | 45.01 | $2.32 | 19.43 |
| 2014-03-31 | 43.23 | $2.06 | 20.95 |
| 2013-12-31 | 39.49 | $1.51 | 26.09 |
| 2013-09-30 | 36.09 | $1.14 | 31.70 |
| 2013-06-30 | 31.00 | $0.39 | 78.55 |
| 2013-03-31 | 32.03 | $0.86 | 37.35 |
| 2012-12-31 | 30.16 | $0.96 | 31.55 |
| 2012-09-30 | 27.94 | $1.44 | 19.41 |
| 2012-06-30 | 24.39 | $1.72 | 14.17 |
| 2012-03-31 | 26.08 | $1.50 | 17.42 |
| 2011-12-31 | 18.80 | $1.71 | 10.99 |
| 2011-09-30 | 17.99 | $1.19 | 15.06 |
| 2011-06-30 | 25.13 | $0.90 | 27.89 |
| 2011-03-31 | 24.47 | $1.15 | 21.30 |
| 2010-12-31 | 23.98 | $1.20 | 19.98 |
| 2010-09-30 | 21.43 | $1.49 | 14.34 |
| 2010-06-30 | 19.07 | $1.72 | 11.11 |
| 2010-03-31 | 21.99 | $1.33 | 16.56 |
| 2009-12-31 | 18.88 | $1.06 | 17.87 |
| 2009-09-30 | 17.58 | $1.35 | 13.07 |
| 2009-06-30 | 15.83 | $1.22 | 12.93 |
| 2009-03-31 | 11.56 | $1.55 | 7.47 |
| 2008-12-31 | 12.53 | $1.54 | 8.15 |
| 2008-09-30 | 22.43 | $1.52 | 14.74 |
| 2008-06-30 | 24.95 | $1.48 | 16.84 |
| 2008-03-31 | 21.66 | $1.45 | 14.98 |
| 2007-12-31 | 23.18 | $1.42 | 16.35 |
| 2007-09-30 | 25.96 | $1.29 | 20.09 |
| 2007-06-30 | 23.10 | $1.32 | 17.55 |
| 2007-03-31 | 21.41 | $0.97 | 22.15 |
| 2006-12-31 | 19.59 | $0.74 | 26.35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.672B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $154.973B | 28.46 |
| HCA Healthcare (HCA) | United States | $108.075B | 17.89 |
| CVS Health (CVS) | United States | $101.885B | 11.72 |
| Elevance Health (ELV) | United States | $72.812B | 10.68 |
| Cencora (COR) | United States | $70.459B | 22.73 |
| Natera (NTRA) | United States | $28.914B | 0.00 |
| DiDi Global (DIDIY) | China | $26.262B | 21.46 |
| Labcorp Holdings (LH) | United States | $22.051B | 16.81 |
| Medpace Holdings (MEDP) | United States | $16.833B | 41.79 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.005B | 0.00 |
| Solventum (SOLV) | United States | $12.806B | 12.43 |
| Viatris (VTRS) | United States | $12.681B | 4.73 |
| CochLear (CHEOY) | Australia | $12.223B | 0.00 |
| HealthEquity (HQY) | United States | $8.659B | 34.65 |
| Charles River Laboratories (CRL) | United States | $8.440B | 16.26 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.989B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.969B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.067B | 36.17 |
| Bausch + Lomb (BLCO) | Canada | $5.880B | 38.60 |
| Sotera Health (SHC) | United States | $4.617B | 22.26 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.944B | 69.26 |
| Alignment Healthcare (ALHC) | United States | $3.322B | 0.00 |
| Concentras Parent (CON) | United States | $2.558B | 15.97 |
| Premier (PINC) | United States | $2.326B | 22.54 |
| Progyny (PGNY) | United States | $2.075B | 40.80 |
| Surgery Partners (SGRY) | United States | $2.051B | 26.43 |
| Ardent Health (ARDT) | United States | $2.011B | 6.57 |
| Organon (OGN) | United States | $2.004B | 2.11 |
| Pediatrix Medical (MD) | United States | $1.949B | 11.64 |
| Establishment Labs Holdings (ESTA) | $1.836B | 0.00 | |
| PACS (PACS) | United States | $1.747B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.326B | 0.00 |
| Omada Health (OMDA) | $1.242B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.063B | 17.00 |
| Embecta (EMBC) | United States | $0.848B | 4.97 |
| CareDx (CDNA) | United States | $0.839B | 13.71 |
| InnovAge Holding (INNV) | United States | $0.772B | 0.00 |
| Nutex Health (NUTX) | United States | $0.676B | 10.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.637B | 8.78 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.562B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Pomdoctor - (POM) | China | $0.457B | 0.00 |
| CryoPort (CYRX) | United States | $0.442B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 18.30 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.81 |
| So-Young (SY) | China | $0.378B | 0.00 |
| SBC Medicals (SBC) | United States | $0.351B | 7.68 |
| Oncology Institute (TOI) | United States | $0.321B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.305B | 0.00 |
| KindlyMD (NAKA) | United States | $0.295B | 0.00 |
| Agilon Health (AGL) | United States | $0.260B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.169B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.58 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |